Clinical scenario analysis: An 85-year-old male with prostate cancer (Gleason 6, PSA $<8$ ng/ml) requires management that accounts for both disease characteristics and patient factors.
Risk stratification:
- Gleason score 6 = low-grade (well to moderately differentiated)
- PSA $<8$ ng/ml = low-risk biochemical marker
- Combined: low-risk localised prostate cancer
Age and life expectancy: At 85 years, expected life expectancy is approximately 5-7 years. Low-risk prostate cancer has a very slow natural history -- the patient is far more likely to die with prostate cancer than from it.
Why active surveillance is correct:
- Radical prostatectomy: major surgical morbidity (incontinence, erectile dysfunction) unacceptable at 85 years
- Radiation: significant side effects (radiation proctitis, cystitis) without survival benefit in this low-risk, elderly group
- TURP: only palliative for obstruction symptoms, not a cancer treatment
- Active surveillance: monitors PSA and clinical status, intervenes only if progression -- optimal risk-benefit ratio
\[\boxed{\text{Answer: D -- Keep on active surveillance}}\]